The Latest Breaking News from FDA

Apellis Pharmaceuticals’ (APLS) stock has jumped more than 25% year-to-date based on FDA approval for treating geographic atrophy. Despite the breakthrough, the company’s ability to scale up production remains a concern. Moreover, its closest competitor is also close to getting approval. Given its poor financials, stretched valuation, and weak profitability,…

Skincare and cosmetics companies have started touting the importance of "clean beauty," but what does that really mean?

Drugmaker Eli Lilly on Wednesday said it will drop prices on some versions of insulin, and cap monthly out-of-pocket costs at $35 per product for insured individuals not covered by Medicare’s prescription drug program, which also maintains a $35 cap. The welcome move comes as lawmakers in both major parties…

Boja Kragulj, an accomplished clarinetist who once performed with orchestras in New York, Philadelphia and Jacksonville, Florida, has already lost four teeth. And she expects to lose at least a dozen more.